Welcome
Support Centre
11 February 2012 
Current Controlled Trials - Clinical Trials
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   news
Introduction
English introduction Introduction en français Deutsche einleitung
Introducción española Introduzione in italiano
 
Find trials
active registers
mental health register
archived registers
all registers
tips on searching
 
 
Information
about mRCT
mRCT FAQs

DISCLAIMER
The site should not be used to diagnose or treat a health problem. Please consult your doctor.
Terms & conditions

DUPLICATION
Your search result may contain a number of different records for the same trial. This occurs when the same trial is listed in more than one register.

[ ...Back to search results ] [ Print-friendly version ]
Test of the open artery hypothesis
Source of recordUK Trials
ISRCTNISRCTN21931925
Date ISRCTN assigned31/10/2001
Local reference number(s)PG/97051
Public titleTest of the open artery hypothesis
Scientific title
AcronymN/A
Disease/condition/study domainCardiovascular disease
Study hypothesisEffect on ventricular modelling of angioplasty and stenting of the occluded infarct related artery (IRA) among patients with their first Q wave anterior myocardial infarction.
Design/methodologyRandomised controlled trial
Research ethics reviewNot provided at time of registration
Countries of trialUnited Kingdom
Participants - inclusion criteriaPatients with Thrombolysis in Myocardial Infarction (TIMI) grade 0 or I.
Participants - exclusion criteriaPatients with TIMI grade II or III in the IRA or multi-vessel disease will be excluded.
Patient information material
Anticipated start date01/03/1997
Anticipated end date01/06/1999
Status of trialCompleted
Target number of participantsNot provided at time of registration
InterventionsAngiography and angioplasty carried out within 28 days of the acute event. Patients to be randomised into intervention or non-intervention groups.
Patients with TIMI grade II or III in the IRA or multi-vessel disease will be excluded.
Remaining patients with TIMI grade 0 or I will be randomised to intervention plus optimal medical therapy or optimal medical therapy alone.
Primary outcome measure(s)Not provided at time of registration
Secondary outcome measure(s)Not provided at time of registration
PublicationsResults in http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12225709
Sources of fundingBritish Heart Foundation (UK) (ref: PG/97051)
Sponsor nameBritish Heart Foundation (UK)
Sponsor details14 Fitzhardinge Street
London
United Kingdom
W1H 6DH
Sponsor telephone+44 (0)20 7935 0185
Sponsor fax+44 (0)20 7486 5820
Sponsor emailresearch@bhf.org.uk
Sponsor websitehttp://www.bhf.org.uk/
Contact nameDr MS Marber
Contact detailsDept of Cardiology
The Rayne Institute
St Thomas' Hospital
Lambeth Palace Road
London
United Kingdom
SE1 7EH
Contact telephone+44 (0)20 7836 5454
Contact emailmike.marber@kcl.ac.uk
More informationFor more up-to-date information please go to the ISRCTN link below.
Link to record in ISRCTN RegisterISRCTN21931925
Date last extracted from ISRCTN register17/04/2008
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 Current Controlled Trials Ltd. Part of Springer Science+Business Media. | terms & conditions | privacy statement


BioMed Central